Mark J Tarr
CIK 1304057 · President & CEO · last filed 2026-08-11
Mark J Tarr is a President & CEO who has filed 105 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider sold $21.7M of EHC on Aug 11, 2026. Across all open-market trades the lifetime net is −$70.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $37.6M across reported positions. 111 SEC filings were submitted jointly with Encompass Health Corp.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
EHC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
9001 LIBERTY PARKWAY
BIRMINGHAM, AL 35242
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EHC | President & CEO | 267,814 | $140.39 | $37.60M | -$67.41M | 48 | 2026-08-11 |
| Encompass Health Corp (HLS) Delisted | President & CEO | 283,134 | — | — | -$2.83M | 44 | 2017-08-08 |
| Encompass Health Corp (HLS.WS) Delisted | President & CEO | 233,962 | — | — | -$586.7K | 8 | 2017-01-05 |
Recent Filings
105 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-11 | EHC | Sell (S) | −173,148 | -$21.72M | EDGAR |
| 2026-08-10 | EHC | Notice (144) | −173,148 | -$21.72M | EDGAR |
| 2026-03-03 | EHC | Mixed | −2,187 | -$235.9K | EDGAR |
| 2026-02-25 | EHC | Tax (F) | −2,488 | -$264.1K | EDGAR |
| 2026-02-23 | EHC | Tax (F) | −45,175 | -$4.84M | EDGAR |
| 2026-02-20 | EHC | Grant (A) | +113,742 | $0 | EDGAR |
| 2026-02-12 | EHC | Sell (S) | −150,000 | -$16.75M | EDGAR |
| 2026-02-11 | EHC | Notice (144) | −150,000 | -$16.74M | EDGAR |
| 2025-05-20 | EHC | Notice (144) | −118,384 | -$14.38M | EDGAR |
| 2025-05-20 | EHC | Mixed | — | -$9.64M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.